Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer

World Journal of Gastroenterology

Volumn 15, Issue 48, 2009, Pages 6061-6067

  Alakus, Hakan ^a   Mönig, Stefan P ^a   Warnecke Eberz, Ute ^a   Alakus, Gül ^b   Winde, Günther ^b   Drebber, Uta ^a   Schmitz, Klaus J ^c   Schmid, Kurt W ^c   Riemann, Kathrin ^c   Siffert, Winfried ^c   Bollschweiler, Elfriede ^a   Hölscher, Arnulf H ^a   Metzger, Ralf ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Klinikum Herford   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

G protein; Gastric cancer; Polymorphism; Prognosis; Tumor stage

Indexed keywords

GENOMIC DNA; GUANINE NUCLEOTIDE BINDING PROTEIN;

ALLELE; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STOMACH CARCINOMA;

EID: 75349095584     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.6061     Document Type: Article

References (30)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64, 1
2. Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-461
3. Sánchez-Bueno F, Garcia-Marcilla JA, Perez-Flores D, Pérez-Abad JM, Vicente R, Aranda F, Ramirez P, Parrilla P. Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 1998; 85: 255-260
4. Bollschweiler E, Breckheimer S, Mönig SP, Hölscher AH. [The prognostic relevance of age and comorbidity in patients with resected gastric cancer] Zentralbl Chir 2009; 134: 71-76
5. Brennan MF. Current status of surgery for gastric cancer: a review. Gastric Cancer 2005; 8: 64-70
6. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005; 8: 86-94
7. Krumins AM, Barber R. Examination of the effects of increasing Gs protein on beta2-adrenergic receptor, Gs, and adenylyl cyclase interactions. Biochem Pharmacol 1997; 54: 61-72
8. Yang X, Lee FY Sr, Wand GS. Increased expression of Gs(alpha) enhances activation of the adenylyl cyclase signal transduction cascade. Mol Endocrinol 1997; 11: 1053-1061
9. Yan L, Herrmann V, Hofer JK, Insel PA. beta-adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol Cell Physiol 2000; 279: C1665-C1674
10. Frey UH, Eisenhardt A, Lümmen G, Rübben H, Jöckel KH, Schmid KW, Siffert W. The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 871-877
11. Frey UH, Lümmen G, Jäger T, Jöckel KH, Schmid KW, Rübben H, Müller N, Siffert W, Eisenhardt A. The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma. Clin Cancer Res 2006; 12: 759-763
12. Frey UH, Alakus H, Wohlschlaeger J, Schmitz KJ, Winde G, van Calker HG, Jöckel KH, Siffert W, Schmid KW. GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer. Clin Cancer Res 2005; 11: 5071-2077
13. Otterbach F, Callies R, Frey UH, Schmitz KJ, Wreczycki C, Kimmig R, Siffert W, Schmid KW. The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma. Breast Cancer Res Treat 2007; 105: 311-317
14. Schmi tz KJ , Lang H, Frey UH, Sot i ropoulos GC, Wohlschlaeger J, Reis H, Takeda A, Siffert W, Schmid KW, Baba HA. GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma. Neoplasia 2007; 9: 159-165
15. Lehnerdt GF, Franz P, Winterhoff S, Bankfalvi A, Grehl S, Lang S, Schmid KW, Siffert W, Jahnke K, Frey UH. The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx. Laryngoscope 2008; 118: 2172-2176
16. Lehnerdt GF, Franz P, Zaqoul A, Schmitz KJ, Grehl S, Lang S, Schmid KW, Siffert W, Jahnke K, Frey UH. Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene. Clin Cancer Res 2008; 14: 1753-1758
17. Frey UH, Nückel H, Sellmann L, Siemer D, Küppers R, Dürig J, Dührsen U, Siffert W. The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia. Clin Cancer Res 2006; 12: 5686-5692
18. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998; 1: 10-24
19. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002; 94: 2511-2516
20. Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 2007; 25: 2107-2116
21. Hansson LE, Sparén P, Nyrén O. Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg 1999; 230: 162-169
22. Kim JP, Kwon OJ, Oh ST, Yang HK. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992; 216: 269-278; discussion 278-279
23. Fleming ID, Cooper JS, Henson DE, Hutter RP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW. Manual for staging of cancer. American Joint Committee on Cancer (AJCC). 5th ed. Philadelphia, PA: Lippincott-Raven, 1997: 71-76
24. Menges M. [Diagnosis, staging and therapy of gastric cancer] Z Gastroenterol 2004; 42: 767-773
25. Yan L, Herrmann V, Hofer JK, Insel PA. beta-adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol Cell Physiol 2000; 279: C1665-C1674
26. Collins MT, Sarlis NJ, Merino MJ, Monroe J, Crawford SE, Krakoff JA, Guthrie LC, Bonat S, Robey PG, Shenker A. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab 2003; 88: 4413-4417
27. Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR. Two G protein oncogenes in human endocrine tumors. Science 1990; 249: 655-659
28. Alakus H, Warnecke-Eberz U, Bollschweiler E, Mönig SP, Vallböhmer D, Brabender J, Drebber U, Baldus SE, Riemann K, Siffert W, Hölscher AH, Metzger R. GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Pharmacogenomics J 2009; 9: 202-207
29. Myklebust JH, Josefsen D, Blomhoff HK, Levy FO, Naderi S, Reed JC, Smeland EB. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J Cell Physiol 1999; 180: 71-80
30. Srivastava RK, Srivastave AR, Cho-Chung YS. Synergistic effects of 8-Cl-cAMP and retinoic acids in the inhibition of growth and induction of apoptosis in ovarian cancer cells: induction of retinoic acid receptor beta. Mol Cell Biochem 2000; 204: 1-9